Jim Miller

The 2001 POMA Sourcing Survey declares 2001 a good year for drug development and manufacturing outsourcing.

Recovery of the contract services industry picked up steam in the quarter ending 30 June 2001.

Evaluating a CRO should involve acquiring feedback from various personnel within the CRO, ranging from executives to line workers.

This project­based quality­improvement program uses short­term goals to achieve the long­term objectives of constant, continuous improvement.

The author forecasts industry mergers and acquisitions activities.

The consolidation of the contract manufacturing industry has spread to the parenteral fill-finish segment, with two deals announced just before this year's Fourth of July holiday.

The vulnerability of both the sponsors and the contractors has increased tremendously.

The author reviews year-to-date progress and growth in the pharmaceutical outsourcing industry.

Numerous risks are inherent to the process of outsourcing. The first line of defense for all parties is continuous diligence.